RE DeGryse
Impact in
- Psychiatry and Mental health top 1%
- Migraine and Headache Studies
- Psychosomatic Disorders and Their Treatments
-
- Trigeminal Neuralgia and Treatments
- Ophthalmology and Eye Disorders
Papers in
-
- Migraine and Headache Studies 9
-
- Botulinum Toxin and Related Neurological Disorders 6
- Co-authors
- DW Dodick (9 shared papers)CC Turkel (9 shared papers)SK Aurora (4 shared papers)RB Lipton (2 shared papers)SD Silberstein (3 shared papers)HC Diener (3 shared papers)Isaac Willis (1 shared paper)Richard B. Lipton (1 shared paper)
- Journals
- The Journal of Headache and Pain (7 papers)Cephalalgia (2 papers)Clinical Drug Investigation (1 paper)
- Partner nations
- United StatesGermanyIreland
In The Last Decade
RE DeGryse
10 papers receiving 1.4k citations
RE DeGryse's Hit Papers
Peers
Comparison fields: 5 of 42
- Psychiatry and Mental health 1.3k
- Pathology and Forensic Medicine 962
- Neurology 513
- Physiology 745
- Sensory Systems 50
Countries citing papers authored by RE DeGryse
This map shows the geographic impact of RE DeGryse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE DeGryse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE DeGryse more than expected).
Fields of papers citing papers by RE DeGryse
This network shows the impact of papers produced by RE DeGryse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE DeGryse. The network helps show where RE DeGryse may publish in the future.
Co-authors
The 9 scholars most cited alongside RE DeGryse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Hit paper breakdown → | 2010 | 744 |
| 2 | OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Hit paper breakdown → | 2010 | 676 |
| 3 | 1991 | 4 | |
| 4 | 2013 | 4 | |
| 5 | 2013 | 3 | |
| 6 | 2013 | 1 | |
| 7 | 2013 | 1 | |
| 8 | 2013 | 1 | |
| 9 | 2013 | 1 | |
| 10 | 2013 | 1 |
About RE DeGryse
RE DeGryse is a scholar working on Psychiatry and Mental health, Neurology, Pathology and Forensic Medicine, Physiology and Surgery, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Migraine and Headache Studies (9 papers), Botulinum Toxin and Related Neurological Disorders (6 papers), Ophthalmology and Eye Disorders (3 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers), Trigeminal Neuralgia and Treatments (2 papers), Cardiovascular Syncope and Autonomic Disorders (1 paper) and Nail Diseases and Treatments (1 paper). The work is most often cited by research in Psychiatry and Mental health (1.3k citations), Pathology and Forensic Medicine (962 citations), Neurology (513 citations), Physiology (745 citations) and Sensory Systems (50 citations). RE DeGryse has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include DW Dodick, CC Turkel, SK Aurora, RB Lipton, SD Silberstein, HC Diener, Isaac Willis, Richard B. Lipton and HC Diener. Their work appears in journals such as The Journal of Headache and Pain, Cephalalgia and Clinical Drug Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.